As COVID-19 patients swamp intensive care units, Health Canada is now reviewing Molnupiravir, an experimental drug claiming to reduce the disease’s worst outcomes. Jamie Mauracher looks at what we know and don’t know about this pill.
- COVID-19 antiviral pill approved in U.K. still being reviewed by Health Canada
- Merck asks U.S. FDA for emergency stamp for COVID-19 tablet
- Experimental pill fights COVID-19, drug-maker Merck claims